Ventana Invests In Project To Get Companion Diagnostics To Market
This article was originally published in The Gray Sheet
Executive Summary
A new project underway at Arizona's Critical Path Institute (C-Path) will help the diagnostics industry and FDA coordinate efforts to streamline the regulatory path for tests used to personalize drug treatment